Evidence map›Paper›PMID 36017377›Full record

ArticleTurkish journal of ophthalmology2022

Frequency of

Neslihan Sinim Kahraman, Ayşe Öner, Yusuf Özkul, Munis Dündar

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Genetics and phenotypes ofMolecular vision · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Neslihan Sinim KahramanAcıbadem Kayseri Hospital, Clinic of Ophthalmology, Kayseri, Turkey.ORCID 0000-0002-1409-1404
Ayşe ÖnerAcıbadem Kayseri Hospital, Clinic of Ophthalmology, Kayseri, Turkey.ORCID 0000-0002-8583-1836
Yusuf ÖzkulErciyes University Faculty of Medicine, Department of Medical Genetics, Kayseri, Turkey.ORCID 0000-0002-4212-5763
Munis DündarErciyes University Faculty of Medicine, Department of Medical Genetics, Kayseri, Turkey.ORCID 0000-0003-0969-4611
Erciyes University · TRKayseri Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Hereditary retinal dystrophies are a rare group of diseases which are heterogeneous in genotype and phenotype and result in total blindness. One of the genetic defects that cause hereditary retinal dystrophy is mutation of the Materials and Methods: The data of patients diagnosed with hereditary retinal dystrophy who were followed up between 2017 and 2021 were retrospectively reviewed. Of these, 460 patients with genetic analysis results were included in the study. The clinical findings of patients with homozygous (biallelic) Results: Conclusion:

Indexed as

cis-trans-IsomerasesRetinal DystrophiesGenetic TherapyHumansMutationRetinoid IsomerohydrolaseRetrospective Studiescis-trans-IsomerasesRetinoid Isomerohydrolasegene therapyhereditary retinal dystrophyRPE65 gene

Identifiers

PMID36017377
PMCPMC9421938
OpenAlexW4293088379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.